Agoracom Blog Home

Posts Tagged ‘Meniscus Tear Repair’

VIDEO – ORTHO Regenerative Technologies $ $ORTIF is Using Proprietary Tech to Improve Surgery Success Rates and Seize a $5bn Market Opportunity

Posted by AGORACOM-JC at 7:17 PM on Sunday, February 21st, 2021

ORTHO Regenerative Technologies is a cutting-edge med tech firm that uses its proprietary RESTORE technology platform to dramatically improve the success rate of orthopedic and sports medicine surgeries.

  • In layman’s terms, that means company has a wonder delivery platform that delivers biologics – drugs made from biological processes – to repair soft tissues in the human body.

The technology uses biologics derived from things like plasma and bone marrow concentrate to regenerate new tissue in various musculoskeletal conditions.

  • This includes Wound Healing, Cartilage repair and Osteo-arthritis

So, how big is the market opportunity for Soft Tissue Repair? At least $5bn in the U.S. alone. This includes:

Rotator Cuff TEAR (which leads to shoulder dysfunction and pain):

  • 4m patients in the U.S. alone
  • 600,000 annual surgeries in the U.S. alone
  • $600m+ market opportunity

Meniscus Tear Repair (which is painful and compromises knee function):

  • There are 1.2m surgeries annually in U.S. alone
  • $1bn+ market opportunity

Cartilage Lesions Repair (this is where lesions cause friction and pain):

  • 1.2m detected lesions annually in U.S. alone
  • 120,000 surgeries and a lack of options
  • $1bn+ market opportunity

Get comfy for this insightful interview with Claude LeDuc, Ortho’s CEO.